Sheri AmbrizVice President of Oligonucleotide Business Development at CPC ScientificSpeaker
Profile
Sheri Ambriz serves as the Vice President of Oligonucleotide Business Development at CPC Scientific. With over 25 years of experience spanning the life sciences, biotechnology, pharmaceutical, and CDMO sectors, she has held a range of leadership roles in process development, research and development, manufacturing, and business development. Sheri holds a B.S. in Biology from the University of California, Santa Cruz, and an MBA from San Francisco State University. She brings extensive expertise in oligonucleotide development and manufacturing, along with a proven track record of strategic leadership and industry insight.
Agenda Sessions
Green Approaches to Peptide and Peptide-Oligonucleotide Manufacturing
, 7:45amView Session